Hikma Pharmaceuticals PLC
OTC: HKMPY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Said Samih Taleb Darwazah
- Employees
- 9,500
- Headquarters
- London, United Kingdom
- IPO year
- 2012
- Market cap
- $4.4B
- Website
- https://www.hikma.com
Loading HKMPY…
Loading profile data…Frequently asked questions about HKMPY
What does Hikma Pharmaceuticals PLC (HKMPY) do?
Hikma Pharmaceuticals PLC is a global pharmaceutical company that specializes in the development, production, commercialization, and distribution of a wide array of generic, branded, and in-licensed medicines. These pharmaceuticals are provided in various final dosage forms, including solid, semi-solid, liquid, and injectable formats. The compan...
Where does HKMPY trade?
Hikma Pharmaceuticals PLC (HKMPY) trades on the Other OTC.
What sector is HKMPY in?
Hikma Pharmaceuticals PLC (HKMPY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hikma Pharmaceuticals PLC?
Said Samih Taleb Darwazah is the chief executive officer of Hikma Pharmaceuticals PLC (HKMPY).
Where is Hikma Pharmaceuticals PLC headquartered?
Hikma Pharmaceuticals PLC is headquartered in United Kingdom.
Does HKMPY pay a dividend?
Yes — Hikma Pharmaceuticals PLC (HKMPY) paid a trailing twelve-month dividend of USD 1.68 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HKMPY go public?
Hikma Pharmaceuticals PLC (HKMPY) completed its initial public offering in 2012.
Is HKMPY an ADR?
Yes — HKMPY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Hikma Pharmaceuticals PLC reporting and dividends follow the underlying issuer.